monocloncal antibodies

Sanofi and Regeneron Pharmaceuticals have revealed that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation status to cemiplimab (REGN2810), an investigational human, monoclonal antibody. more

11 Sep 2017 14:30 News

Primary data from the CANTOS Phase III trial (sponsored by Novartis) has revealed that a treatment that targets inflammation reduces the risk of cardiovascular disease. more

29 Aug 2017 16:26 News

Robert Turok, SPX Flow, discusses high yield spray drying of monoclonal antibodies and its use in the production of fine biopharmaceutical powders. more

13 Oct 2016 15:40 News

BioCellChallenge has announced its positive results from in-vivo tests of a therapeutic antibody more

1 Dec 2015 15:16 News

amp biosimilars has announced its first successful out-licensing of biosimilar ABY-018, a humanised monoclonal antibody. At present, there are four biosimilars in the ampb product pipeline. more

29 May 2015 10:30 News

Contract testing organisation BioOutsource has amplified its position as a global leader in antibody drug conjugates (ADC) characterisation and announced a partnership with Glythera Ltd, an emerging biotechnology company based in Newcastle-upon... more

18 Feb 2014 10:13 Technology

BioOutsource, a biologics contract testing and biosimilar characterisation services provider to the biopharmaceutical industry, has announced the opening of a new Biosimilar Centre of Excellence in Glasgow, Scotland. The new facility will double... more

5 Feb 2014 11:24 Technology

BioOutsource, a leading international contract testing organisation (CTO), has consolidated its position as a leading expert in the biological analysis of biosimilar monoclonal antibodies for the biopharmaceutical industry. more

23 Sep 2013 14:56 Technology

Merck Millipore, the Life Science division of Merck, has introduced two additions to the company’s comprehensive chromatography portfolio that further accelerate downstream purification. more

17 Sep 2013 15:51 Technology

Apeiron Biologics, a biotech company focused on immunologic and biologic therapies against cancer, and Rentschler Biotechnologie, a full service biopharmaceutical contract manufacturer, have jointly announced a partnership agreement to manufacture... more

1 Aug 2013 11:41 Technology